Home/Pipeline/FreeStyle Libre 3

FreeStyle Libre 3

Diabetes Management - Continuous Glucose Monitoring

Marketed (Global)Launch Imminent/Recent in IndiaN/A

Key Facts

Indication
Diabetes Management - Continuous Glucose Monitoring
Phase
Marketed (Global)
Status
Launch Imminent/Recent in India
Company

About Abbott India

Abbott India's mission is to create new healthcare solutions that help people live their best lives, leveraging its parent company's global R&D while adapting to India's unique needs. The company has achieved a dominant market position with a valuation exceeding $550 billion, reflecting its extensive portfolio and deep market penetration. Its strategy centers on leveraging Abbott's global innovation pipeline, local manufacturing in Goa, and a multi-divisional approach to capture growth across India's expanding healthcare sectors.

View full company profile